Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6827473 | Schizophrenia Research | 2011 | 6 Pages |
Abstract
This study suggests that drug use-related impairment co-morbid with schizophrenia may not be a function of use per se but rather, of the severity of use. It highlights the importance of comprehensive assessment and treatment of illicit substance abuse in schizophrenia. Long-term treatment approaches that integrate harm reduction strategies may offer promise in maximizing positive outcomes for such dually diagnosed patients.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Karin E. Kerfoot, Robert A. Rosenheck, Ismene L. Petrakis, Marvin S. Swartz, Richard S.E. Keefe, Joseph P. McEvoy, T. Scott Stroup, CATIE Investigators CATIE Investigators,